(19)
(11) EP 1 701 724 A2

(12)

(88) Date of publication A3:
15.09.2005

(43) Date of publication:
20.09.2006 Bulletin 2006/38

(21) Application number: 04815779.6

(22) Date of filing: 29.12.2004
(51) International Patent Classification (IPC): 
A61K 31/4375(2006.01)
(86) International application number:
PCT/US2004/043777
(87) International publication number:
WO 2005/067502 (28.07.2005 Gazette 2005/30)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
LV

(30) Priority: 02.01.2004 US 533892 P

(71) Applicant: Merck & Co., Inc.
Rahway, NJ 07065-0907 (US)

(72) Inventors:
  • GOBLE, Stephen, D.
    Rahway, New Jersey 07065-0907 (US)
  • YANG, Lihu
    Rahway, New Jersey 07065-0907 (US)
  • ZHOU, Changyou
    Rahway, New Jersey 07065-0907 (US)
  • KOTHANDARAMAN, Shankaran
    Rahway, New Jersey 07065-0907 (US)
  • GUIADEEN, Deodialsingh
    Rahway, New Jersey 07065-0907 (US)
  • BUTORA, Gabor
    Rahway, New Jersey 07065-0907 (US)
  • PASTERNAK, Alexander
    Rahway, New Jersey 07065-0907 (US)
  • MILLS, Sander, G.
    Rahway, New Jersey 07065-0907 (US)

(74) Representative: Man, Jocelyn 
Merck & Co.,Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) ALKYLAMINO, ARYLAMINO, AND SULFONAMIDO CYCLOPENTYL AMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY